Cold Kit
DMSA
This radiopharmaceutical kit after being labeled with Tc-99m, is used for static imaging of kidneys in the
following cases
DTPA
DTPA is suitable agent for dynamic scintigraphy of
the kidneys, for glomerular filtration rate
measurements, for radionuclide angiocardiography,
for visualization of the brain tumours.
HEDP
The radiopharmaceutical is used for skeletal
scintigraphy in order to identify foci of pathological
changes of various origins and prevalence;
primary and metastatic malignant tumors,
osteomyelitis, osteoarticular
tuberculosis, arthritis of various origins.
MAA
This kit is used to detect Lung perfusion scan
Pulmonary embolism and myocardial infraction
Chronic circulatory failureRegional respiratory
distress Emphysema etc.
MDP
MDP is suitable agent for bone scintigraphy, has
proven valuable in the detection of primary and
metastatic tumours, osteomyelitics, bone-joint
tuberculosis etc.
MIBI
MIBI is suitable agent for evoluation of the
myocardium perfusion at its different pathological
states and for the scintigraphy of the malignant
tumors of the lung and breast.
PYP
Pyrophosphate Injection is a skeletal imaging agent
used to demonstrate areas of altered osteogenesis,
and a cardiac imaging agent used as an adjunct in
the diagnosis of acute
Peptide
DOTA-TOC
Being labeled with radioisotope, Synthetic analogues of somatostatin interact with specific somatostatin
receptors on the cell surface. A high concentration of these receptors is specific for neuroendocrine
tumors.
DOTA-TATE
Being labeled with radioisotope, Synthetic analogues of somatostatin interact with specific somatostatin
receptors on the cell surface. A high concentration of these receptors is specific for neuroendocrine
tumors.
DOTA-NOC
Being labeled with radioisotope, Synthetic analogues of somatostatin interact with specific somatostatin
receptors on the cell surface. A high concentration of these receptors is specific for neuroendocrine
tumors.
HEDP
Hydroxyethyl Dehyde diphosphonate (HEDP) is used
to relieve the severe pain of bone metastases in
cancer patients. After labeling with rhenium-188 this theranostic radiopharmaceutical kit is capable of
relieving this type of pain and increasing the patient’s quality of life.
PSMA
PSMA ligands bind to prostate-specific membrane
antigen, an enzyme most highly expressed in
prostate cancer cells. The high specificity of binding
is the reason of their use in nuclear medicine. The
products labeled with fluorine-18 (F-18) and gallium-68 (Ga-68) are used for diagnostic purposes.
Radiopharmaceuticals with lutetium-177 (Lu-177)
and actinium-225 (Ac-225) are used to treat the
specific diseases.